Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.05 (0.29%)
Bid:
16.55
Ask:
17.00
Spread: 0.45 (2.719%)
Market Cap: £21.50m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

Director/PDMR Shareholding

17 Nov 2023 17:54

RNS Number : 8948T
Cirata PLC
17 November 2023

[17] November 2023

Cirata plc

("Cirata" or the "Company")

Director/PDMR Shareholdings

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Cirata plc (LSE: CRTA) provides the following notification of a transaction by persons discharging managerial responsibilities ("PDMR").

On 17 November 2023, Mr Stephen Kelly, Chief Executive Officer, purchased 248,600 Ordinary Shares in Cirata at a price of 48 pence per Ordinary Share. Following this purchase and on completion of the Allotment Award share matching transaction, Mr Stephen Kelly will be the beneficial owner of 2,032,600 Ordinary Shares representing approximately 1.76% of the Company's "when issued" share capital.

The total beneficial shareholding of 2,032,600 Ordinary Shares is comprised of open market purchases by Mr Stephen Kelly totalling 1,182,680 Ordinary Shares, plus the company's share Allotment Award of 850,000[1] Ordinary Shares, giving a total beneficial ownership post allotment of 2,032,600 Ordinary Shares.

The following represents the Director dealing

Buying PMDR

Ordinary shares purchased

Price of Ordinary Shares acquired, 17 November 2023

Total beneficial interest post purchase

Mr Stephen Kelly, CEO

248,600

48 pence

1,182,680

The following represents the Directors beneficial interest post the "Allotment Award" Shares

Transaction

Shares / %

Shareholding as of COB 16 Nov 23

1,182,680

Allotment Award Shares

850,000

Total beneficial Interest post Allotment Award

2,032,680

% beneficial Ordinary Share ownership post Allotment Award

1.76%

"Allotment Award"/Allotment Award Shares"

As previously disclosed on 3 July "Launch of Fund Fundraise" under the terms of Mr Stephen Kelly's service agreement, the Company has agreed (up to a capped limit) that during the 12-month period from the commencement of service, for every Ordinary Share purchased by Mr Stephen Kelly in the open market the Company will issue and allot on a 1-1 basis a match to this purchase. This shall be limited to a maximum value of 1 times £425,000 (based on the price per Ordinary Share paid) (the "Allotment Award Shares").

The number of shares purchased by Mr Stephen Kelly that are eligible for a match have exceeded the capped limit of £425,000 (The book value of open market purchases to date is approximately £545,000). As a result, under the terms of the Allotment Award, Mr Stephen Kelly will be issued a further 850,000 Ordinary Shares. The Allotment Award Shares will be issued by the financial year end 2023.[2]

The Notification of Dealing Form for this transaction is included at the end of this announcement.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

This announcement contains information that qualifies or may qualify as inside information. The person responsible for arranging the release of this announcement on behalf of Cirata plc is Larry Webster, Company Secretary.

Cirata plc

Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ijoma Maluza, Chief Financial Officer

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / Ben Cryer / Miquela Bezuidenhoudt

About Cirata

Cirata accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Kelly

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cirata plc

b)

LEI

213800Y1A75RSC698O04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares 10 p each

ISIN: JE00B6Y3DV84

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

48 pence

248,600

d)

Aggregated information

- Aggregated volume

- Price

248,600

48 pence

e)

Date of the transaction

17 October 2023

f)

Place of the transaction

London Stock Exchange (XLON)


[1] The number of shares allocated (850,00) is derived by taking the agreed value cap of £425,000 and dividing by the purchase price per share (50 pence per share) of Mr Stephen Kelly's open market trades.

[2] The Company's issued share capital at 1 November 2023 consisted of 114,898,711 ordinary shares of ten pence each with voting rights admitted to trading. The Company holds no ordinary shares in Treasury. Upon completion of the Allotment Share Awards the issued share capital will increase by 850,000 shares leading to a total of 115,748,711 issued share capital.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBRBDBXUBDGXR
Date   Source Headline
1st Jun 20267:00 amRNSBlock Listing Return
20th May 20267:00 amRNSResult of AGM
5th May 20267:00 amRNSHolding(s) in Company
23rd Apr 20268:52 amRNSAmendment to Notice of Annual General Meeting
21st Apr 20267:00 amRNSGrant of Awards & PDMR Dealing
14th Apr 20267:00 amRNSTrading Statement
31st Mar 20263:39 pmRNSManagement Changes
31st Mar 20267:00 amRNSPreliminary Results
4th Feb 20268:54 amRNSGrant of Awards & PDMR Dealing
14th Jan 20267:00 amRNSQ4 FY25 Trading Update
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
1st Dec 20259:35 amRNSBlock Listing Return
27th Nov 20257:00 amRNSFinancial Conduct Authority Update
17th Nov 20257:00 amRNS$6.7m Multiyear Contract win
27th Oct 202510:05 amRNSNotification of Major Holdings
16th Oct 20257:00 amRNSTrading Statement
13th Oct 20257:00 amRNS$3.1m Multiyear Contract with leading US Insurer
12th Sep 202511:02 amRNSGrant of Awards & PDMR Dealing
10th Sep 20257:00 amRNSNotification of Major Holdings
9th Sep 20258:00 amRNS-RCirata launches new data platform
3rd Sep 20257:00 amRNSInterim results
13th Aug 20257:00 amRNSGrant of Share Options to PDMRs
11th Aug 20257:00 amRNSCompletion of DevOps Divestment
15th Jul 20257:07 amRNSQ2 and H1FY25 Trading Update
30th Jun 20257:01 amRNSHolding(s) in Company
30th Jun 20257:00 amRNS$700K Multiyear Data Integration Contract Renewal
10th Jun 20257:00 amRNSBoard Appointment
3rd Jun 20252:39 pmRNSBlock Listing Return
8th May 20254:47 pmRNSResult of AGM
29th Apr 202511:44 amRNSGrant of Share Options to PDMRs
16th Apr 20257:00 amRNSQ1FY25 Trading Statement
8th Apr 20257:00 amRNSAnnual Report & Notice of AGM
2nd Apr 20253:51 pmRNSNotification of Major Holdings
31st Mar 20257:01 amRNSContract win
31st Mar 20257:00 amRNSPreliminary Results
27th Feb 20257:00 amRNSNew logo in Telecom sector
20th Feb 20257:00 amRNSTotal Voting Rights
20th Jan 20256:29 pmRNSPDMR dealings and Total Voting Rights
9th Jan 20257:00 amRNSQ4FY24 Trading Update
16th Dec 20247:00 amRNSContract Win and FY24 Guidance
13th Dec 20243:46 pmRNSVesting of Restricted Stock & Director Dealings
11th Dec 20247:00 amRNSIssue of Equity
9th Dec 20247:00 amRNSMarvell Contract Renewal
2nd Dec 20243:40 pmRNSBlock Listing Return
1st Nov 20247:00 amRNSGrant of Share Options to PDMRs
24th Oct 20247:00 amRNSPDMR Transactions
9th Oct 20247:00 amRNSQ3 Trading Update and Outlook
2nd Oct 20243:19 pmRNSAmendment of OEM sales partnership with IBM
1st Oct 20247:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.